Pulmonx Corporation (LUNG) vs vTv Therapeutics Inc. (VTVT)

A side-by-side comparison of Pulmonx Corporation and vTv Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — LUNG vs VTVT

growth of $100 · dividends reinvested · last 6y
LUNG -95.2% (-39.8%/yr)VTVT -57.2% (-13.2%/yr)VTVT compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100202120222023202420252026$5$43
LUNG VTVT

LUNG vs VTVT: by the numbers

  • •VTVT is the larger company ($78M vs $75M market cap).
  • •Both run net losses; VTVT's is the smaller (-12.91% vs -55.03% net margin).
  • •LUNG grew revenue faster over the past five years (15.86% vs -18.12% CAGR).

Metrics side by side

Valuation

MetricLUNGVTVT
P/S ratio0.862.13
P/B ratio1.911.00

Profitability

MetricLUNGVTVT
Gross margin77.06%0.00%
Operating margin-52.96%0.00%
Net margin-55.03%-12.91%
ROE-122.76%-6.05%
ROIC-48.39%-11.48%

Growth (annualized)

MetricLUNGVTVT
Revenue CAGR (5Y)15.86%-18.12%
Total return CAGR (5Y)-45.30%-13.55%

Frequently asked

Which has grown faster, LUNG or VTVT?
Over the past five years, LUNG grew revenue faster — LUNG at a 15.86% CAGR versus VTVT at -18.12%.
How have LUNG and VTVT total returns compared?
Over the past 5 years, LUNG delivered -45.30% and VTVT delivered -13.55% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.